You have 9 free searches left this month | for more free features.

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

Recruiting
  • Cytarabine+Thiotepa + Fludarabine + Busulfan
  • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • cytarabine+thiotepa+ fludarabine + busulfan
  • Hangzhou, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 26, 2022

Relapsed/Refractory, High Risk Hematologic Malignancies, T-ALL/Lymphoma Trial in Langfang (CD7CAR T cells)

Recruiting
  • Relapsed/Refractory, High Risk Hematologic Malignancies
  • T-ALL/Lymphoma
  • CD7CAR T cells
  • Langfang, Hebei, China
    Hebei Yanda Lu Daopei Hospital
Jun 30, 2022

T-cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (Senl-T7)

Recruiting
  • T-cell Acute Lymphoblastic Leukemia/Lymphoma
  • Senl-T7
  • Beijing, Hebei, China
    Hebei yanda Hospital
Nov 22, 2022

T-cell Acute Lymphoblastic Leukemia Trial in Beijing (CD5 CAR-T)

Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • CD5 CAR-T
  • Beijing, Beijing, China
    Xuanwu Hospital Capital Medical University
Oct 23, 2022

Acute Lymphoblastic Leukemia Trial in Tianjin (CN201)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Oct 14, 2022

T-Cell Acute Lymphoblastic Leukemia Trial in Shenzhen (Antigen-specific T cells CAR-T/CTL and DCvac)

Recruiting
  • T-Cell Acute Lymphoblastic Leukemia
  • Antigen-specific T cells CAR-T/CTL and DCvac
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Mar 14, 2022

Tisagenlecleucel in Brazilian Acute Lymphoblastic Leukemia or

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Acute Lymphoblastic Leukemia
  • tisagenlecleucel
  • (no location specified)
Sep 13, 2022

T-Cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (CD5 CAR T (CT125B))

Recruiting
  • T-Cell Acute Lymphoblastic Leukemia/Lymphoma
  • CD5 CAR T (CT125B)
  • Beijing, Beijing, China
    Beijing Gaobo Boren Hospital
Aug 3, 2022

Pediatric ALL, B Cell, Minimal Residual Disease Trial in Seoul (Blinatumomab for Injection)

Recruiting
  • Pediatric ALL, B Cell
  • Minimal Residual Disease
  • Blinatumomab for Injection
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Feb 20, 2022

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial (Cyclophosphamide, Vincristine, Dexamethasone)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • B Lymphoblastic Lymphoma
  • (no location specified)
Aug 2, 2022

Acute Myeloid Leukemia, T Cell Acute Lymphoblastic Leukemia, T Cell Lymphoblastic Lymphoma Trial in Milwaukee (XmAb18968 - Dose

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • XmAb18968 - Dose level -1
  • +4 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Feb 15, 2022

Acute Lymphoblastic Leukemia, Leukemia Trial in Houston (Ponatinib, Venetoclax, Mini-hyper CVD)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Aug 23, 2022

B-cell Acute Lymphoblastic Leukemia, Lymphoblastic B-Cell Lymphoma Trial in Minsk (CD19 CAR-T-cells, Tocilizumab)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Lymphoblastic B-Cell Lymphoma
  • Minsk, Minsk Region, Belarus
    Belarussian Research Center for Pediatric Oncology, Hematology a
Apr 12, 2022

T-cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Yanda (CD7 CAR-T)

Completed
  • T-cell Acute Lymphoblastic Leukemia/Lymphoma
  • CD7 CAR-T
  • Yanda, Hebei, China
    Hebei yanda Ludaopei Hospital
Jun 23, 2021

FoxO3a and PU.1 in Acute Lymphoblastic Leukemia

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • complete blood count
  • (no location specified)
Feb 15, 2022

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an

Recruiting
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • +2 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Sep 29, 2021

B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Lymphoma (B-ALL) Trial (PIT565)

Not yet recruiting
  • B-cell Non-Hodgkin Lymphoma (B-NHL)
  • B-cell Acute Lymphoblastic Lymphoma (B-ALL)
  • PIT565
  • (no location specified)
Jun 13, 2022

Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

Active, not recruiting
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • gene-modified T cells targeted
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2022

T-lymphoblastic Lymphoma, Relapsed Disease, Refractory Lymphoma Trial in Shanghai (BCL2 Inhibitor plus IM2 regimen)

Not yet recruiting
  • T-lymphoblastic Lymphoma
  • +5 more
  • BCL2 Inhibitor plus IM2 regimen
  • Shanghai, Shanghai, China
    Shanghai General hospital,Shanghai Jiao Tong University School o
Oct 11, 2022

Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That

Not yet recruiting
  • Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
  • Inotuzumab Ozogamicin
  • (no location specified)
Oct 24, 2022

B-cell Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Apr 4, 2022

T Cell Lymphoblastic Lymphoma Trial in Beijing (BT-007 CD7 CAR-T cells)

Recruiting
  • T Cell Lymphoblastic Lymphoma
  • BT-007 CD7 CAR-T cells
  • Beijing, China
    Beijing Cancer Hospital
Sep 22, 2022

T Lymphoblastic Leukemia/Lymphoma, T-cell Acute Lymphoblastic Leukemia, Peripheral T Cell Lymphoma Trial in Shanghai (anti-CD7

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • +4 more
  • anti-CD7 CAR-T cells
  • Shanghai, China
    Xianmin General Song
May 3, 2022

T-cell Acute Lymphoblastic Leukemia, T-Cell Acute Lymphoblastic Lymphoma Trial (Daratumumab)

Not yet recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • T-Cell Acute Lymphoblastic Lymphoma
  • (no location specified)
Jul 13, 2021

B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab, Conventional therapy)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The first affiliated hospital of Soochow University
Sep 26, 2022